multimodal treatment

Multi-Modality Therapy | New Studies | Statistics

Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
ByHolly Zink November 21, 2023November 3, 2023

Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper understanding of mesothelioma and its effects on people. Pleural mesothelioma is a serious type of cancer that affects the lining of the lungs. It is caused by asbestos exposure. Doctors have found that the outlook for people with this cancer depends on different factors. They include the type of cancer cells and how far the cancer has spread in the body. A group of researchers studied 169 patients with pleural mesothelioma over a period of 10 years to learn more about this disease and how it affects people. A Look at ‘Performance Status’ The researchers used a special computer program…

Read More Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
Chemotherapy | Surgery | Treatments

Mesothelioma Treatment Roadmap: Connecting Chemotherapy Response and Surgical Outcomes
ByHolly Zink September 7, 2023August 30, 2023

Mesothelioma patients who do not respond well to chemotherapy before surgery are likely to have poor outcomes after the procedure. This is the finding of a group of researchers from the University of Texas MD Anderson Cancer Center. How Chemotherapy Response Shapes Mesothelioma Surgery Outcomes Mesothelioma is a rare type of cancer that is hard to diagnose and treat. It develops from the thin layer of tissue that covers many of the body’s internal organs. Mesothelioma is caused by exposure to a toxic mineral called asbestos. In most cases, doctors will use more than one type of treatment to remove as many cancer cells as possible from a patient’s body. The standard therapies include chemotherapy, radiation, and surgery. Of all…

Read More Mesothelioma Treatment Roadmap: Connecting Chemotherapy Response and Surgical Outcomes
Chemotherapy | Multi-Modality Therapy | Radiation Therapy | Surgery | Treatments

Hemithoracic Radiotherapy for Mesothelioma
ByHolly Zink May 17, 2023

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Read More Hemithoracic Radiotherapy for Mesothelioma
Chemotherapy | Multi-Modality Therapy | Radiation Therapy | Surgery | Treatments

Hemithoracic Radiotherapy for Mesothelioma
ByHolly Zink May 16, 2023

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Read More Hemithoracic Radiotherapy for Mesothelioma
Updates

Understanding the New Multimodality Prognostic Score (MMPS) in Mesothelioma
ByHolly Zink May 10, 2022April 25, 2022

The Multimodality Prognostic Score (MMPS) is a new tool for evidence-based mesothelioma treatment. It has given clinicians and surgeons a new guideline in multimodality treatment. The treatment options for mesothelioma are many. Often, one treatment alone cannot control cancer so many treatment types are required. Multimodal therapy can be tailored to each patient’s case. The Multimodality Prognostic Score (MMPS) has an update. It is a tool in the clinician’s toolbox for outlining a treatment plan. Surgical Options Surgery is a common treatment option for malignant pleural mesothelioma. There are two surgeries that are most common. The first is pleurectomy and decortication (P/D) surgery. The second is an extrapleural pneumonectomy (EPP). Pleurectomy and decortication surgery (P/D) is a common pleural mesothelioma…

Read More Understanding the New Multimodality Prognostic Score (MMPS) in Mesothelioma
Multi-Modality Therapy | New Studies | Research | Surgery | Treatments

A Multimodality Treatment Plan may be Best for Pleural Mesothelioma
ByHolly Zink February 4, 2022January 10, 2022

A multimodality treatment plan may improve mesothelioma patient outcomes. Malignant pleural mesothelioma is an invasive, locally aggressive tumor related to asbestos exposure. A new study shows that the best treatment plan for pleural mesothelioma may be when different types of therapy work together. The ideal combination of treatment therapies is still unknown. But a recent study encourages further studies on a multimodality treatment plan. This may include chemotherapy, surgery, and adjuvant radiotherapy. Current Clinical Guidelines: A History of Single or Multimodality Treatment Plans Despite a long history of clinical research, there is still no cure or any evidence of the best treatment. Many single-treatment plans, single-modality plans, have had disappointing results. Researchers have begun to evaluate different multi-modal treatment approaches….

Read More A Multimodality Treatment Plan may be Best for Pleural Mesothelioma
Europe | International | Multi-Modality Therapy | Prognosis | Treatments

Long-Term Mesothelioma Survival: Follow-up is Critical
ByAlex Strauss November 30, 2020

A newly published French case report is a reminder that long-term mesothelioma survival requires long-term follow-up. The case comes from Aix-Marseille University in Marseille. In the Annals of Medicine and Surgery, doctors wrote about a man who survived mesothelioma for 14 years. In all that time, his cancer did not progress. The situation is unusual for mesothelioma. The life expectancy of most mesothelioma patients is about 18 months. Prolonged survival is two years or more. But the authors of the new report say their case shows that long-term mesothelioma survival is not impossible with the right approach. Treatment for Malignant Mesothelioma Malignant mesothelioma usually occurs in people who have lived or worked around asbestos. Many do not know they have…

Read More Long-Term Mesothelioma Survival: Follow-up is Critical
International | Multi-Modality Therapy | New Studies | Research | Treatments

Multimodal Mesothelioma Treatment Doubles Survival in Mexican Study
ByAlex Strauss October 8, 2020

Researchers at Mexico’s National Cancer Institute say multimodal mesothelioma treatment with chemotherapy, surgery, and radiation can slow tumor growth and improve survival. Their new study of patients with advanced pleural mesothelioma produced a median survival of nearly two years. That is almost twice as long as average for pleural mesothelioma. The researchers say the key is a multimodal mesothelioma treatment approach that attacks tumors from three different angles. Chemotherapy Alone is Rarely Enough Chemotherapy is still the main treatment for most patients with pleural mesothelioma. The FDA approved pemetrexed (Alimta) in 2004. Until the recent approval of a combination of Opdivo and Yervoy, Alimta was the only drug for mesothelioma. It is still the main component in mesothelioma chemotherapy. But…

Read More Multimodal Mesothelioma Treatment Doubles Survival in Mexican Study
Chemotherapy | Immune Systems | Immunotherapy | Multi-Modality Therapy | Research | Treatments

Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
ByAlex Strauss June 17, 2020

There is new evidence that the immunotherapy drug durvalumab may make chemotherapy more effective for people with inoperable pleural mesothelioma. Researchers recently achieved record mesothelioma survival times with this combination. Mesothelioma is a rare cancer with a poor prognosis. Surgery can sometimes help if it is caught early. But only a small percentage of patients are candidates for mesothelioma surgery. Most have chemotherapy, which is only moderately effective. But new research presented to the nation’s largest gathering of cancer doctors shows the immunotherapy drug durvalumab may help. Doctors at Johns Hopkins combined durvalumab with standard mesothelioma chemotherapy. Study participants lived an average of 8 months longer than is typical with this disease. If further studies confirm the benefit, it could…

Read More Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
Chemotherapy | Europe | International | Multi-Modality Therapy | Radiation Therapy | Surgery | Treatments | Updates

Mesothelioma Patients Live Longer with Multimodal Treatment
ByAlex Strauss March 5, 2015March 25, 2019

Another new study has confirmed that a multimodal approach – in which multiple treatments are used together – is the most reliable way to improve survival in patients with malignant pleural mesothelioma. Doctors in England and Italy have just published their findings on a mesothelioma treatment combination that includes surgery, pleural lavage, radiotherapy and systemic chemotherapy. The study included 102 mesothelioma patients treated between 2004 and 2013 at one of two London hospitals or at the University of Milan. About three quarters of the patients in the study had the epithelioid variety of mesothelioma, which is the most common form. Eighty percent were male. All of the patients underwent the lung-sparing mesothelioma surgery called pleurectomy/decortication (PD) during which the diseased…

Read More Mesothelioma Patients Live Longer with Multimodal Treatment

Get your free copy of

“Surviving Mesothelioma” Today

Get Your Free Copy »